Bed Bath & Beyond Inc. (BBBY)
Chart Events
Performance Outlook
| Previous Close | 24.91 |
| Open | 24.91 |
| Bid | 25.34 x 1000 |
| Ask | 25.35 x 900 |
| Day's Range | 24.74 - 25.73 |
| 52 Week Range | 4.32 - 53.90 |
| Volume | 612,771 |
| Avg. Volume | 12,693,663 |
| Market Cap | 2.765B |
| Beta (5Y Monthly) | 1.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.24 |
| Earnings Date | Jul 06, 2021 - Jul 12, 2021 |
| Forward Dividend & Yield | 0.68 (17.94%) |
| Ex-Dividend Date | Mar 12, 2020 |
| 1y Target Est | 26.23 |
- TheStreet.com
Bed Bath & Beyond's Charts Have Us Checking Our Hospital Corners
For his second "Executive Decision" segment of Wednesday's Mad Money program, host Jim Cramer spoke with Mark Tritton, president and CEO of Bed Bath & Beyond , the home goods retailer. Tritton said he's been encouraged by their performance as more and more stores reopen. Tritton was also upbeat about the company's Bye Bye Baby franchise .
- CorpGov.com
Roumell Asset Management Sends Letter to Enzo Biochem On Co-Founder’s Resignation
By Jarrett Banks Roumell Asset Management LLC filed an amended 13D on Enzo Biochem Inc. expressing its disapproval that the company hasn’t accepted Co-Founder Elazar Rabbani’s board resignation. Enzo Biochem, Inc., founded in the 1970s, has frustrated investors with a poor operational and share-price performance over the last several years. CorpGov has covered the story extensively. “Shareholders demonstrated […]
- Motley Fool
Why Bed Bath & Beyond Stock Fell 13% in April
What happened Bed Bath & Beyond (NASDAQ: BBBY) shares dropped by 13% in April, according to data provided by S&P Global Market Intelligence -- a particularly lackluster performance given the 5.2% spike that the S&P 500 registered for the month.
